Business Developer at EFS (France 2030 PIBT integrator). We help biotech and technology companies de-risk and scale cell therapy processes to GMP-ready. Open to connect with cell therapy innovators and tech providers.
EFS BFC (Bourgogne-Franche-Comté) is part of the French Blood Service (EFS) and hosts the PIBT (Innovation Hub in Biotherapies), a France 2030 industrial integrator dedicated to the maturation of advanced therapies. We support biotech companies and bioproduction technology providers in bridging the gap between early-stage development and GMP-ready manufacturing. Our activities focus on de-risking cell therapy projects through process optimisation, scale-up strategies and integration of innovative bioproduction technologies. With access to EFS national bioproduction platforms and strong expertise in cell-based therapies, we act as a key interface between R&D and manufacturing to accelerate the development of robust, scalable and regulatory-ready processes.
We support biotech, pharma and academic teams in advancing cell and gene therapy projects from early development to robust, scalable and GMP-ready processes through tailored process development, scale-up and CMC support.
We support technology providers in evaluating, validating and integrating innovative bioproduction solutions for cell and gene therapies through real-use testing, benchmarking and process development.